Longeveron® Announces Second Quarter 2024 Financial Results and Provides Business Update
14 août 2024 16h05 HE
|
Longeveron
Longeveron reports Q2 2024 financial results and provides business update. Phase 2b clinical trial in HLHS achieves 70% enrollment.
Advanced Therapy Medicinal Products Global Strategic Business Report 2023-2030: Rising Demand for Gene Therapy Spurs Market Expansion, North America and Europe Dominate
13 août 2024 11h06 HE
|
Research and Markets
Dublin, Aug. 13, 2024 (GLOBE NEWSWIRE) -- The "Advanced Therapy Medicinal Products - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market...
Meso Numismatics, a Renowned Leader in Regenerative Medical, Announces Global Stem Cells Groups (GSCG) Launch of Revolutionary New Line of Peptides
13 août 2024 06h33 HE
|
Meso Numismatics, Inc.
LAS VEGAS, NV, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Meso Numismatics, Inc. (“Meso Numismatics” or the “Company”) (MSSV), a renowned leader in regenerative medical company, and in the process with FINRA...
Longeveron® to Report Second Quarter 2024 Financial Results and Host Conference Call on August 14, 2024
05 août 2024 16h05 HE
|
Longeveron
Longeveron announced that it will report Q2 2024 financial results and provide a business update on Wednesday, August 14, 2024.
Exosome Diagnostics and Therapeutics Research Report 2024: Market to Grow at a Staggering CAGR of 81.2% by 2032
02 août 2024 10h48 HE
|
Research and Markets
Dublin, Aug. 02, 2024 (GLOBE NEWSWIRE) -- The "Global Exosome Diagnostics and Therapeutics Market by Type (Diagnostics, Therapeutics), Product & Service (Instruments, Kits, Reagents), Source...
NurExone Announces the Transfer of Manufacturing of the Active Element in ExoPTEN Drug to a Commercial GMP Manufacturer
01 août 2024 16h04 HE
|
NurExone Biologic Inc
NurExone Announces the Transfer of Manufacturing of the Active Element in ExoPTEN Drug to a Commercial GMP Manufacturer
Longeveron® Presents Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ in Mild Alzheimer’s Disease at the Alzheimer’s Association International Conference® (AAIC)
28 juil. 2024 16h51 HE
|
Longeveron
Longeveron Phase 2a clinical results in Alzheimer's Disease selected for Featured Research oral presentation at Alzheimer’s Association International Conf
Tissue Engineering Market Size is Expected to Reach USD 12.43 Billion by 2032, Growing at a CAGR of 14.40%: Straits Research
18 juil. 2024 10h20 HE
|
Straits Research Private Limited - Garner Insights
New York, United States, July 18, 2024 (GLOBE NEWSWIRE) -- As per the Latest Report by Straits Research, the global tissue engineering market size was valued at USD 4,333.61 million in 2023. It is...
Gene Therapy Agreements Analysis Report and Directory 2024: Comprehensive Listing of 740 Deals Announced Since 2016
17 juil. 2024 05h31 HE
|
Research and Markets
Dublin, July 17, 2024 (GLOBE NEWSWIRE) -- The "Gene Therapy Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Gene Therapy Collaboration and...
Regenerative Medicine Market to Surpass USD 83.6 Billion by 2031 | Skyquest Technology
12 juil. 2024 09h06 HE
|
SkyQuest Technology Consulting Pvt. Ltd.
Westford, USA, July 12, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the global regenerative medicine market will attain a value of USD 83.6 billion by 2031, with a CAGR of 27.2% during the...